Sugi Predict

Sugi Predict / Compounds / SCHEMBL1669099

SCHEMBL1669099

SCHEMBL1669099

Cc1ccccc1C(N)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 1/20 0.50
▸ GAA P10253 1/20 0.44
▸ TSHR P16473 1/20 0.43
▸ ACHE P22303 1/20 0.43
▸ ACP3 P15309 1/20 0.42
▸ ALDH1A1 P00352 3/20 0.41
▸ SLC6A2 P23975 2/20 0.40
▸ SLC6A4 P31645 2/20 0.40
▸ SLC6A3 Q01959 2/20 0.40
▸ CYP3A4 P08684 2/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ ADRA2A P08913 1/20 0.38
▸ ADRA2C P18825 1/20 0.38
▸ LMNA P02545 1/20 0.38
▸ HIF1A Q16665 1/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ CYP2D6 P10635 1/20 0.37
▸ KCNH2 Q12809 1/20 0.37
▸ MAOA P21397 1/20 0.36
▸ MAOB P27338 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13993318 0.84 ESR1 (0.59) ESR1GAATSHRACHEACP3
SCHEMBL30507724 0.81 ESR1 (0.56) ESR1GAATSHRACHEACP3
SCHEMBL5051416 0.81 KDM4E (0.56) ESR1GAATSHRACHEACP3
SCHEMBL6765024 0.81 LMNA (0.40) TSHRALDH1A1SLC6A2CYP3A4ADRA2A
SCHEMBL15270254 0.79 ESR1 (0.45) ESR1GAATSHRACHEACP3
SCHEMBL24017139 0.79 ESR1 (0.54) ESR1GAATSHRACHEACP3
SCHEMBL895700 0.79 ESR1 (0.54) ESR1GAATSHRACHEACP3
SCHEMBL3255909 0.79 ESR1 (0.54) ESR1GAATSHRACHEACP3
SCHEMBL12569046 0.79 ESR1 (0.54) ESR1GAATSHRACHEACP3
SCHEMBL4577367 0.79 ESR1 (0.54) ESR1GAATSHRACHEACP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2486115-A1 ELECTRORHEOLOGICAL FLUID COMPRISING ORGANIC DOPANTS, AND USE THEREOF Fraunhofer Gesellschaft zur Förderung der angewandten Wissenschaft E.V. (DE) 2012-08-15 — — EP claimed
WO-2011042117-A1 ELECTRORHEOLOGICAL FLUID COMPRISING ORGANIC DOPANTS, AND USE THEREOF Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) 2011-04-14 — — WO claimed
EP-3745207-B1 PATTERN-FORMING METHOD USING ELECTRON BEAMS FOR EUV RAYS AND USE OF THIS METHOD FOR FORMING A FINE CIRCUIT OF A SEMICONDUCTOR DEVICE FUJIFILM CORP (JP) 2021-06-16 — — EP disclosed
US-10570148-B2 N-alkyl-2-phenoxyethanamines, their preparation and use THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2020-02-25 — — US disclosed
US-20180222919-A1 N-ALKYL-2-PHENOXYETHANAMINES, THEIR PREPARATION AND USE THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2018-08-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10570148-B2 N-alkyl-2-phenoxyethanamines, their preparation and use HRH3, CBR3, KCNH3 ESR1 1693/4885GAA 4382/4885TSHR 969/4885
US-20180222919-A1 N-ALKYL-2-PHENOXYETHANAMINES, THEIR PREPARATION AND USE HRH3, CBR3, KCNH3 ESR1 1693/4885GAA 4382/4885TSHR 969/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.